```

[Congressional Bills 118th Congress]
[From the U.S. Government Publishing Office]
[H.R. 7189 Enrolled Bill (ENR)]

        H.R.7189

                     One Hundred Eighteenth Congress

                                 of the

                        United States of America

                          AT THE SECOND SESSION

         Begun and held at the City of Washington on Wednesday,
         the third day of January, two thousand and twenty-four

                                 An Act

 
    To amend the Public Health Service Act to reauthorize a national 
congenital heart disease research, surveillance, and awareness program, 
                         and for other purposes.

    Be it enacted by the Senate and House of Representatives of the 
United States of America in Congress assembled,
SECTION 1. SHORT TITLE.
    This Act may be cited as the ``Congenital Heart Futures 
Reauthorization Act of 2024''.
SEC. 2. REAUTHORIZATION OF NATIONAL CONGENITAL HEART DISEASE RESEARCH, 
SURVEILLANCE, AND AWARENESS PROGRAM.
     Section 399V-2 of the Public Health Service Act (42 U.S.C. 280g-
13) is amended--
        (1) by redesignating subsections (f) and (g) as subsections (g) 
    and (h), respectively;
        (2) by inserting after subsection (e) the following:
    ``(f) Report and Strategy.--
        ``(1) Report.--Not later than 2 years after the date of 
    enactment of the Congenital Heart Futures Reauthorization Act of 
    2024, the Secretary shall issue a report to the Committee on Energy 
    and Commerce of the House of Representatives and the Committee on 
    Health, Education, Labor, and Pensions of the Senate including the 
    following:
            ``(A) A description of past and present activities of the 
        Department of Health and Human Services to increase awareness 
        and knowledge of the public with respect to congenital heart 
        disease, including efforts to address the lifelong needs of 
        congenital heart disease patients.
            ``(B) An assessment of past and present activities of the 
        Department of Health and Human Services to increase education 
        and training of health care providers with respect to 
        congenital heart disease, including efforts to address the 
        lifelong needs of congenital heart disease patients.
            ``(C) A description of the current workforce capacity in 
        the United States of health care providers who treat adult 
        patients living with congenital heart disease.
        ``(2) Strategy.--
            ``(A) Development; submission to congress.--Not later than 
        1 year after submitting the report required by paragraph (1), 
        the Secretary shall develop and submit to Congress a strategy 
        for improving efforts to increase awareness and knowledge of 
        the public and education and training of health care providers 
        with respect to congenital heart disease. Such strategy shall 
        include findings and recommendations to--
                ``(i) address any public awareness and research gaps 
            and opportunities related to the lifelong needs of 
            congenital heart disease patients, including long-term 
            health outcomes, quality of life, mental health, and health 
            care utilization;
                ``(ii) address any shortages in the current workforce 
            of health care providers who treat adult patients living 
            with congenital heart disease, which may include strategies 
            to enhance fellowship training programs or other continuing 
            education programs; and
                ``(iii) foster collaboration and dissemination of 
            information across Federal agencies, health care providers, 
            researchers, and patient organizations.
            ``(B) Consultation.--In developing the strategy under 
        subparagraph (A), the Secretary shall, as appropriate, consult 
        with qualified stakeholder groups, including patient 
        organizations, health care professionals, research entities, 
        health insurance providers, accrediting organizations, and 
        relevant Federal agencies, including the Centers for Disease 
        Control and Prevention, the National Institutes of Health, and 
        the Health Resources and Services Administration.''; and
        (3) in subsection (h), as so redesignated, by striking ``2020 
    through 2024'' and inserting ``2025 through 2029''.

                               Speaker of the House of Representatives.

                            Vice President of the United States and    
                                               President of the Senate.
```